Roivant Sciences Ltd. (ROIV): Price and Financial Metrics
ROIV Price/Volume Stats
| Current price | $11.49 | 52-week high | $13.06 |
| Prev. close | $11.31 | 52-week low | $8.56 |
| Day low | $11.23 | Volume | 3,070,300 |
| Day high | $11.51 | Avg. volume | 5,826,608 |
| 50-day MA | $11.69 | Dividend yield | N/A |
| 200-day MA | $11.21 | Market Cap | 8.50B |
ROIV Stock Price Chart Interactive Chart >
Roivant Sciences Ltd. (ROIV) Company Bio
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
ROIV Price Returns
| 1-mo | -2.05% |
| 3-mo | -3.28% |
| 6-mo | 4.64% |
| 1-year | 27.67% |
| 3-year | 46.00% |
| 5-year | N/A |
| YTD | 2.32% |
| 2023 | 40.55% |
| 2022 | -20.73% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...